Hard NAPLEX USP 795 Practice Questions

Mastering non-sterile compounding standards is a critical component of the pharmacy licensure exam, and these Hard NAPLEX USP 795 Practice Questions are designed to test your knowledge of the most recent 2023 revisions. This article provides a deep dive into beyond-use date (BUD) calculations, facility requirements, and quality assurance protocols necessary for safe pharmacy practice.

Concept Explanation

USP Chapter 795 provides the minimum standards for non-sterile compounding to ensure the quality, strength, and purity of preparations while protecting both the patient and the compounder. The core focus of USP 795 involves the categorization of compounding into simple, moderate, and complex levels, alongside strict requirements for the physical environment, personal protective equipment (PPE), and documentation. A major pillar of this chapter is the determination of Beyond-Use Dates (BUD), which were significantly updated in the 2023 revision to reflect the presence or absence of preservatives and the water activity $a_w$ of the final preparation.

To succeed on the exam, candidates must understand that USP 795 applies to all healthcare settings where non-sterile preparations are compounded, including community pharmacies and hospital settings. You can find more comprehensive resources in our NAPLEX Prep hub. Key requirements include a designated compounding area that is separate from high-traffic zones and the maintenance of a Compounding Record (CR) and Master Formulation Record (MFR) for every unique preparation.

According to the United States Pharmacopeia, non-sterile compounding must also adhere to strict cleaning and sanitizing schedules. For instance, work surfaces must be cleaned at the beginning and end of each shift and after any spill. When preparing for high-stakes exams, using tools like an AI Exam Simulator can help reinforce these specific regulatory details through repetitive exposure.

Solved Examples

1. BUD Calculation for Aqueous Oral Liquid: A pharmacist compounds a 1% Propranolol oral solution using purified water. The preparation does not contain a preservative and is stored in a refrigerator. What is the maximum BUD?

   1. Identify the preparation type: Non-sterile aqueous oral liquid.

   2. Determine preservative status: Non-preserved.

   3. Apply USP 795 limits: For non-preserved aqueous dosage forms stored in a refrigerator, the BUD is 14 days.

   4. Final Answer: 14 days.

2. Component Selection: A pharmacist is compounding a topical cream and needs to select an ingredient. The USP-NF grade is unavailable. What is the next preferred source according to USP 795?

   1. Review the hierarchy of ingredients: USP, NF, or Food Chemicals Codex (FCC) marks are preferred.

   2. If these are unavailable, the pharmacist must use professional judgment to select a high-quality source, such as an Analytical Reagent (AR) or American Chemical Society (ACS) certified grade.

   3. The pharmacist must also obtain a Certificate of Analysis (CoA) for the component.

   4. Final Answer: Use a high-quality grade (AR or ACS) and obtain a CoA.

3. Water Activity Calculation: A preparation has a water activity $a_w$ of 0.55. Based on USP 795, is this considered an aqueous or non-aqueous dosage form?

   1. Recall the threshold for water activity: Aqueous dosage forms have an $a_w \geq 0.6$.

   2. Compare the value: 0.55 < 0.6.

   3. Determine the category: Because the water activity is less than 0.6, it is classified as a non-aqueous dosage form.

   4. Final Answer: Non-aqueous dosage form.

Practice Questions

1. A pharmacist compounds an anhydrous ointment containing several active pharmaceutical ingredients (APIs). The preparation is stored at controlled room temperature. According to USP 795, what is the maximum beyond-use date (BUD) that can be assigned in the absence of stability data?

2. Which of the following is a mandatory requirement for the designated compounding area under USP 795 standards?

3. A technician is preparing a preserved aqueous topical lotion. The final preparation is stored at room temperature. What is the maximum BUD allowed by USP 795?

4. When compounding a preparation that requires a Master Formulation Record (MFR), which of the following elements is NOT required to be included in the MFR?

5. A pharmacist is compounding a pediatric suspension using a manufactured tablet as the source of the API. The tablet has an expiration date of 6 months from today. The standard BUD for the compounded suspension is 14 days. What BUD should be assigned?

6. According to USP 795, how often must the walls, ceilings, and storage shelving in the non-sterile compounding area be cleaned and sanitized?

7. A non-aqueous oral formulation is prepared using a spirit and a fixed oil. If the water activity $a_w$ is measured at 0.45, what is the maximum BUD if stored at room temperature?

8. Which of the following scenarios would categorize a non-sterile preparation as "Complex" compounding?

9. A pharmacist prepares a preserved aqueous oral liquid. The stability of the API is known to be 60 days based on a peer-reviewed journal article, but the USP 795 limit for this category is 35 days. What BUD should be assigned?

10. During the compounding of a progesterone cream, the pharmacist realizes the electronic balance has not been calibrated today. According to USP 795, what is the requirement for equipment calibration?

Answers & Explanations

1. 180 days. For non-aqueous dosage forms (like an anhydrous ointment), the maximum BUD is 180 days when stored at room temperature or refrigerated. This is a significant increase from the previous 90-day limit in older versions of the chapter.

2. The area must be well-lit and have controlled temperature and humidity. USP 795 requires that the compounding area be specifically designated, have adequate space, and be maintained in a clean and orderly condition with environmental controls to ensure the stability of components.

3. 90 days. For preserved aqueous non-oral liquids (like a topical lotion) where the water activity $a_w \geq 0.6$, the maximum BUD is 90 days when stored at room temperature or refrigerated.

4. The name of the technician who prepared the specific batch. This information belongs in the Compounding Record (CR), not the Master Formulation Record (MFR). The MFR is the "recipe" or template, while the CR is the documentation of a specific batch.

5. 14 days. The BUD cannot exceed the expiration date of any component or the USP 795 limit, whichever is shorter. Since 14 days is much shorter than 6 months, the 14-day limit applies.

6. Every 3 months (quarterly). While work surfaces are cleaned daily, USP 795 specifies that walls, ceilings, and shelving must be cleaned every 3 months or when visibly soiled.

7. 180 days. Since the water activity is &lt; 0.6, it is treated as a non-aqueous dosage form, which allows for a BUD of 180 days.

8. Compounding a transdermal patch or a specialized drug delivery system. Complex compounding involves preparations requiring special training, equipment, or procedures, such as modified-release dosage forms or transdermal delivery systems.

9. 35 days. USP 795 states that the BUD cannot exceed the limits set in the chapter unless there is specific stability data (e.g., a stability-indicating assay) for that exact formulation. Peer-reviewed literature may be used as a guide, but the chapter limits usually prevail unless the study matches the formulation exactly.

10. Equipment must be calibrated or verified before use on the day it is used. USP 795 requires that balances and other equipment be checked for accuracy daily before use to ensure the precision of the compounding process.

For students looking to master these nuances, exploring Hard NAPLEX Renal Therapeutics Practice Questions can provide additional context on how drug stability affects patients with impaired clearance.

1. What is the maximum BUD for a non-preserved aqueous oral liquid stored in the refrigerator?

• A7 days
• B14 days
• C30 days
• D35 days

Frequently Asked Questions

What is the difference between a Master Formulation Record and a Compounding Record?

The Master Formulation Record is a permanent document that lists the ingredients and instructions for a specific preparation. In contrast, the Compounding Record is completed each time a preparation is made, documenting the specific batch details like lot numbers and the person who performed the compounding.

Can I extend a BUD beyond USP 795 limits using a journal article?

A BUD can only be extended beyond the chapter's default limits if there is a stability-indicating assay performed on the exact formulation and container-closure system. General information from a journal article is often insufficient unless it perfectly replicates the pharmacy's specific conditions and ingredients.

What are the gowning requirements for non-sterile compounding?

Pharmacists and technicians must wear gloves and a lab coat at a minimum; however, additional PPE like hair covers or masks may be required based on the risk of contamination or the nature of the ingredients. Gloves must be changed if they become torn or contaminated during the process.

Does USP 795 apply to the simple reconstitution of a manufactured antibiotic?

No, USP 795 generally does not apply to the simple reconstitution of a FDA-approved drug according to the manufacturer's labeling. However, if any modifications are made to the manufacturer's instructions, such as adding a flavoring agent not listed in the labeling, USP 795 standards then apply.

How should hazardous non-sterile drugs be handled?

While USP 795 covers the compounding process, hazardous drugs are primarily governed by USP 800. Pharmacies must use a dedicated containment primary engineering control (C-PEC) and follow specific cleaning protocols to prevent cross-contamination and protect staff from exposure.

To further sharpen your clinical skills, consider reviewing Hard NAPLEX Antimicrobial Stewardship Practice Questions or use our Retrieval Challenge for daily practice.